About Oral Genome
Oral Genome is a private company based in Carlsbad, California, incorporated in 2021 in Delaware. It has reported $3,225,645 raised in four offerings on Form D since November 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 14, 2025 | Jan 31, 2025 | $3,107,595of $5.1M target | 37 | $83,989 | EquityRule 506(b) | Form D ↗ |
| Nov 9, 2022 | Nov 23, 2022 | $75,000fully sold | 1 | $75,000 | DebtRule 506(c) | Form D ↗ |
| Apr 20, 2022 | Apr 25, 2022 | $13,050fully sold | 1 | $13,050 | EquityRule 506(c) | Form D ↗ |
| Oct 21, 2021 | Nov 5, 2021 | $30,000fully sold | 1 | $30,000 | EquityRule 506(c) | Form D ↗ |
| Total, four offerings | $3,225,645 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Oral Genome's Form D filed Jan 31, 2025.
TP
Tim Pranger
Director
TS
Tina Saw
Executive officer and director
Earlier filings also listed Thanh Luu (executive officer and director, last listed Nov 2022).